Aeterna Zentaris
AEZS
#10198
Rank
C$24.19 M
Marketcap
C$7.90
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): C-$2.77

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is C-$2.83. In 2022 the company made an earnings per share (EPS) of C-$6.47 a decrease over its 2021 EPS that were of C-$2.51.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$2.77
2022C-$6.47157.14%
2021C-$2.51-41.48%
2020C-$4.30-64.46%
2019C-$12.09-240%
2018C$8.63-122.32%
2017C-$38.68-53.53%
2016C-$83.24-86.71%
2015C-$626.51-35.21%
2014C-$967.05-216.67%
2013C$828.90-123.3%
2012C-$3,557-40.8%
2011C-$6,010-6.45%
2010C-$6,424-27.91%
2009C-$8,911-61.61%
2008C-$23,20983.61%
2007C-$12,641-195.31%
2006C$13,262178.26%
2005C$4,766-330%
2004C-$2,072-80.05%
2003C-$10,38717.78%
2002C-$8,819515.93%
2001C-$1,432-68.6%
2000C-$4,560119.62%
1999C-$2,076-3.63%
1998C-$2,155

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Spectrum Pharmaceuticals
SPPI
C-$0.50-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.17-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
C$4.10-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.12-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
C$6.76-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA